Sign in
Taking peopleNo phase

Looking at liver problems in adults with Turner syndrome

Studies how often liver changes occur in adult women with Turner syndrome.

Key facts

Who runs it
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants
Status
Recruiting
People taking part
120 people, planned
Started
7 Jan 2025
Planned end
7 Jan 2026
Type of study
Observational
Record updated
27 January 2025

Who can take part

The trial is looking for adult women with Turner syndrome. It studies how often liver changes happen in blood tests and scans.

Age
18 years or older
Sex
Female
Disease stage
Turner syndrome confirmed by a chromosome test (karyotype) on a blood sample.
Earlier treatment
People taking drugs that cause large changes in liver enzymes cannot join.
Biomarker or test result
Turner syndrome shown by karyotype analysis on peripheral blood.
Main reasons for not taking part
  • Taking drugs that cause significant changes in liver enzyme levels (liver function alteration, LFA)
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • Diagnosis of Turner syndrome made by karyotype analysis on peripheral blood
  • Age 18 years or older
  • Written informed consent obtained

Who cannot take part

  • TS patients on therapy with drugs responsible for significant liver enzyme alterations (liver function alteration, LFA)

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sex
  • Turner syndrome

This trial is currently available in Italy.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The present study is therefore aimed at investigating the prevalence of hepatic alterations (laboratory and imaging) in adult patients with TS and generating hypothesissto the possible etiopathogenetic factors most involved, as well as evaluating the correlation between biochemical and structural abnormalities.

Read full original descriptionShow less

Thus, the study could provide relevant etiopathogenetic and prognostic results on the development of hepatopathy in TS patients.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Characterization of Hepatopathy in Turner Syndrome: Analysis of Determinants in an Observational Study
Plain-language title
Looking at liver problems in adults with Turner syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06794190, who can take part
Record updated
27 January 2025